Analyst Ratings for [CANO] Cano Health, Inc.

8/11/23	Downgrades	Buy Neutral	X
CANO Cano Health Citigroup
$4 $0.80
8/11/23	Downgrades	Buy Hold	X
CANO Cano Health Jefferies
1/6/23	Downgrades	Buy Neutral	X
CANO Cano Health UBS
$12 $1.25
1/5/23	Downgrades	Outperform Peer Perform	X
CANO Cano Health Wolfe Research
12/13/22	Resumed	Underperform	X
CANO Cano Health BofA Securities
$1.50
11/10/22	Downgrades	Outperform Mkt Perform	X
CANO Cano Health Cowen
$10 $3
11/10/22	Downgrades	Outperform Mkt Perform	X
CANO Cano Health Raymond James
10/27/22	Downgrades	Outperform Neutral	X
CANO Cano Health Credit Suisse
$10 $5
9/23/22	Drops	Neutral	X
CANO Cano Health BofA Securities
9/7/22	Initiated	Hold	X
CANO Cano Health Truist
$7
6/24/22	Initiated	Outperform	X
CANO Cano Health Raymond James
$8
6/15/22	Downgrades	Buy Neutral	X
CANO Cano Health BofA Securities
$8 $6
5/3/22	Initiated	Buy	X
CANO Cano Health BofA Securities
$8

CANO Cano Health, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. As of December 31, 2021, it operated 130 owned medical centers and approximately 1000 affiliate providers serving approximately 227,005 members. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.